Skip to main content

Drug Interactions between ginkgo and trazodone

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

traZODone ginkgo

Applies to: trazodone and ginkgo

MONITOR: The coadministration of low-dose trazodone and ginkgo biloba was associated with the development of ataxia, drowsiness, and coma in an elderly patient with Alzheimer's disease. The patient had received a total of 100 mg trazodone and 320 mg ginkgo biloba in an approximately 50-hour period. The effects were reversed by flumazenil. The mechanism of interaction proposed by the investigators is a synergistic GABAergic effect due to partial agonistic action of ginkgo biloba at benzodiazepine binding sites and increased liberation of GABA by an active metabolite of trazodone. Ginkgo may also induce the metabolism of trazodone to this active metabolite. However, causality was not clearly determined due to the presence of a benzodiazepine, which had been discontinued the day before the trazodone was initiated.

MANAGEMENT: In general, patients should consult a healthcare provider before taking any herbal or alternative medicine. Caution may be appropriate when combining ginkgo products with trazodone, especially in the elderly. Patients should be advised of the potential for increased sedation or other central nervous system effects.

References (2)
  1. Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB (2000) "Coma in a patient with Alzheimer's disease taking low dose trazodone and ginkgo biloba." J Neurol Neurosurg Psychiatry, 68, p. 679-83
  2. Izzo AA, Ernst E (2001) "Interactions between herbal medicines and prescribed drugs: a systematic review." Drugs, 61, p. 2163-75

Drug and food interactions

Moderate

traZODone food

Applies to: trazodone

GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.

MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.

References (4)
  1. Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
  2. Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
  3. (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
  4. (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.